News from neuronetics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 16, 2014, 13:00 ET

Data Published Online in The Journal of Clinical Psychiatry Show Long-Term Benefit of Non-Drug NeuroStar TMS Therapy® in Patients with Treatment Resistant Depression

 Neuronetics, Inc., today announced that results of a study designed to assess the long-term effectiveness of  NeuroStar TMS Therapy in...

May 06, 2014, 14:30 ET

Non-Drug NeuroStar TMS Therapy Shows Favorable Outcomes Compared to Oral Antidepressants in Treating Major Depressive Disorder

 Neuronetics, Inc. announced today a new analysis of data at the annual meeting of the American Psychiatric Association that shows Transcranial...

May 05, 2014, 14:30 ET

NeuroStar TMS Therapy® Shows Promise as Effective Once-Monthly Maintenance Therapy in Patients with Major Depressive Disorder

 Neuronetics, Inc. announced today results from a new, dual-arm randomized pilot study that showed a trend toward symptomatic improvements with...

Sep 16, 2013, 09:55 ET

Data Published in CNS Spectrums Indicate Acute Transcranial Magnetic Stimulation (TMS) with NeuroStar TMS Therapy® Improves Quality of Life in Patients with Depression

Neuronetics, Inc., today announced that results of a naturalistic, observational study from 42 clinical trial sites in the United States, which...

Jul 30, 2013, 08:30 ET

Neuronetics, Inc., Announces First Patients Enrolled in Clinical Trial to Evaluate NeuroStar TMS Therapy in Women with Postpartum Depression

 Neuronetics, Inc., the maker of a non-drug depression treatment, announced today the enrollment of the first five patients in an open-label...

May 29, 2013, 14:59 ET
Neuronetics named one of the top 100 North American companies by Red Herring.  (PRNewsFoto/Neuronetics, Inc.)

Red Herring Names Neuronetics as One of the Top 100 North American Companies for 2013

 Neuronetics, Inc., a privately-held medical device company committed to the development of innovative, non-invasive therapies to treat...

May 21, 2013, 17:00 ET

New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System

New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System® induced...

Mar 19, 2013, 10:30 ET

NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes

 New data released today at the annual meeting of the American Academy of Neurology show that transcranial magnetic stimulation (TMS)...

Oct 16, 2012, 12:54 ET

Neuronetics, Inc., Honored with Prestigious Industry Award for the NeuroStar TMS Therapy® System at Phoenix 2012 Conference

 Neuronetics, Inc., a privately-held medical device company committed to the development of innovative, non-invasive therapies to treat...

Jun 04, 2012, 14:10 ET

Neuronetics, Inc. recibe la aprobación de CE Mark para la terapia NeuroStar TMS

- La solución no invasiva y no de fármaco ofrece esperanza a millones de adultos que viven con depresión Neuronetics, Inc. ha...

Jun 04, 2012, 14:06 ET

Neuronetics, Inc. erhält CE-Zulassung für NeuroStar TMS Therapy

- Nicht-invasive, nicht-medikamentöse Lösung bietet Hoffnung für Millionen unter Depression leidenden Erwachsenen Neuronetics,...

Jun 04, 2012, 09:00 ET

Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy

 Neuronetics, Inc. announced today the receipt of CE Mark approval for its NeuroStar TMS Therapy® System for the treatment of Major...

Jun 04, 2012, 05:00 ET

Neuronetics, Inc. obtient le marquage CE pour le système NeuroStar TMS Therapy

- Une solution non-invasive, non-médicamenteuse donne l'espoir à des millions d'adultes souffrant de la dépression La...

May 08, 2012, 11:00 ET
Neuronetics, Inc. Logo.  (PRNewsFoto/Neuronetics, Inc.)

Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life

 New data released today at the annual meeting of the American Psychiatric Association show that patients with unipolar, non-psychotic Major...

Sep 02, 2010, 16:06 ET

Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer

Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® system, has been selected by the World Economic...

May 17, 2010, 14:50 ET

Data Continue to Demonstrate Value of NeuroStar TMS Therapy as a Proven Treatment for Patients Battling Difficult-to-Treat Depression

Neuronetics, Inc. announced today that in addition to independent research by the National Institute of Mental Health (NIMH), new data exploring...

Nov 12, 2009, 09:00 ET

Photo: NeuroStar TMS Therapy(R) Receives Prestigious Popular Science Award

Quick Facts - Neuronetics' NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy has been selected by Popular Science as one...

May 19, 2009, 15:00 ET

Study Shows NeuroStar TMS Therapy(R) Improved Key Elements of Cognition in Patients with Major Depressive Disorder

Unlike Electroconvulsive Therapy (ECT), NeuroStar TMS Therapy Is Not Associated With Memory Loss New data presented today at the American...

Apr 21, 2009, 10:08 ET
A F NEURONETICS NEUROSTAR TMS NEURONETICS NEUROSTAR TMS

NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy is a new treatment for depression. (PRNewsFoto/Neuronetics, Inc.)[MF]
 MALVERN, PA UNITED STATES
 04/21/2009

Photos: NeuroStar TMS Therapy(R) Recipient of Medical Design Excellence Award

Novel device for the treatment of depression named one of 2008's top medical device innovations - NeuroStar(R) TMS (Transcranial Magnetic...

Nov 06, 2008, 09:06 ET

New Study Demonstrates Cost Effectiveness of NeuroStar TMS Therapy(R) in the Treatment of Depression

Cost Savings for the Health Care System May Be Expected With NeuroStar Relative to Standard Care in Patients With Inadequate Benefit to Prior...